Tenet Healthcare Corporation (THC)
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
Tenet Healthcare's Surge Isn't Over Yet
Tenet Healthcare (THC) remains a compelling 'buy' due to strong growth, margin expansion, and deep undervaluation versus peers. THC's Ambulatory Care segment drives profitability, with nearly half of projected EBITDA from just 24% of revenue. Management has aggressively reduced leverage and repurchased $1.19B in stock, signaling balance sheet strength and shareholder alignment.
Tenet Healthcare Soars 72% YTD: But is the Rally Out of Breath?
THC's 71.8% surge, lifted guidance and expanding outpatient reach fuel optimism, but valuation and policy risks pose lingering questions.
Tenet (THC) Up 4% Since Last Earnings Report: Can It Continue?
Tenet (THC) reported earnings 30 days ago. What's next for the stock?
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare Shares Down 5% Despite Q3 Earnings Beat
THC's Q3 profit beats estimates on higher revenues and strong segment growth, but rising costs drag shares lower.
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare Corporation (THC) Q3 2025 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q3 2025 Earnings Call October 28, 2025 10:30 AM EDT Company Participants William McDowell - Vice President of Investor Relations Saumya Sutaria - Chairman & CEO Sun Park - Executive VP & CFO Conference Call Participants Kevin Fischbeck - BofA Securities, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Craig Hettenbach - Morgan Stanley, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Ryan Langston - TD Cowen, Research Division Justin Lake - Wolfe Research, LLC Brian Tanquilut - Jefferies LLC, Research Division Albert Rice - UBS Investment Bank, Research Division Joshua Raskin - Nephron Research LLC Benjamin Mayo - Leerink Partners LLC, Research Division Thomas Walsh - Barclays Bank PLC, Research Division Presentation Operator Good morning, welcome to Tenet Healthcare's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I'll now turn the call over to your host, Mr.
